ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:587-592. doi:10.1016/j.athoracsur.2007.09.041
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Willem Flameng
Bart Meuris
Paul Herijgers
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flameng, W.
Right arrow Articles by Herregods, M.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flameng, W.
Right arrow Articles by Herregods, M.-C.
Related Collections
Right arrow Valve disease


Original Articles: Cardiovascular

Trilogy Pericardial Valve: Hemodynamic Performance and Calcification in Adolescent Sheep

Willem Flameng, MD, PhDa,*, Bart Meuris, MD, PhDa, Geofrey De Visscher, PhDa, Crystal Cunanan, MSb, Ernie Lane, BSb, Erik Verbeken, MD, PhDa, Paul Herijgers, MD, PhDa, Marie-Christine Herregods, MD, PhDa

a Laboratory of Experimental Cardiac Surgery, Department of Cardiovascular Diseases, Katholieke Universiteit (K. U.) Leuven, Leuven, Belgium
b Arbor Surgical Technologies, Irvine, California

Accepted for publication September 20, 2007.

* Address correspondence to Prof Dr Flameng, Cardiac Surgery, University Clinic Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium (Email: willem.flameng{at}med.kuleuven.be).

Background: We assessed the hemodynamic performance and calcification potential of a new design of bovine pericardial valve, the Trilogy valve (Arbor Surgical Technologies Inc, Irvine, CA). We compared this new valve with the Perimount valve (Edwards Lifesciences, Irvine, CA) in a randomized prospective study in adolescent sheep.

Methods: Nine Trilogy valves (size 21) and six Perimount valves (size 23 or 25) were implanted in the mitral position in adolescent sheep and studied during five months. Hemodynamic measurements were performed at one week, three months, and five months using transthoracic echocardiography. Valve calcification was assessed by X-ray and calcium content was measured by atomic absorption spectrometry after five months implantation in sheep. Tissues were also evaluated histologically (Von Kossa staining).

Results: The nine Trilogy valves had lower peak velocity, peak gradient, and mean gradient compared with the six Perimount valves. These 21-mm Trilogy valves had similar deceleration time and effective orifice area compared with the 23- and 25-mm Perimount valves. Calcification of the Trilogy valves was significantly lower than Perimount valves (p < 0.01), particularly in the commissural (p < 0.01) and free margin regions (p < 0.03). In all parameters assessed, the Trilogy valves exhibited less variation valve-to-valve compared with Perimount valves.

Conclusions: These findings demonstrate that a valve designed to reduce stress in the tissue, improve leaflet kinematics, with advanced antimineralization treatment, can exhibit superior calcification resistance in the mitral position of adolescent sheep. The trilobal geometry and independent leaflet suspension design, combined with an advanced tissue treatment, appears to be a promising breakthrough in the effort to develop a more durable and hemodynamically efficient bioprosthetic valve.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.